Oral 5-aminosalicylic acid for inflammatory bowel disease in pregnancy: Safety and clinical course
Authors:
- Gavin HuiGHGavin Hui
- Gordon R. GreenbergGGGordon R. Greenberg
- 1 October 1993
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 105 (4) , 1057-1060
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Oral 5-aminosalicylic acid (Asacol) in the maintenance treatment of Crohn's diseaseGastroenterology, 1992
- Advances in Drug Therapy for Inflammatory Bowel DiseaseAnnals of Internal Medicine, 1990
- CARDIAC HYPERSENSITIVITY TO 5-AMINOSALICYLIC ACIDThe Lancet, 1989
- Acute Pancreatitis Due to 5-AminosalicylateAnnals of Internal Medicine, 1989
- Double-Blind Comparison of Slow-Release 5-Aminosalicylateand Sulfasalazine in Remission Maintenance in Ulcerative ColitisGastroenterology, 1988
- Inflammatory Bowel Disease in Pregnancy: A ReviewJournal of the Royal Society of Medicine, 1986
- Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis.Gut, 1980
- AN EXPERIMENT TO DETERMINE THE ACTIVE THERAPEUTIC MOIETY OF SULPHASALAZINEThe Lancet, 1977
- Adverse Reactions during Salicylazosulfapyridine Therapy and the Relation with Drug Metabolism and Acetylator PhenotypeNew England Journal of Medicine, 1973
- Nephrotoxic Lesions from 5-Aminosalicylic AcidBMJ, 1972